key: cord-0834232-3u0qrddf authors: Leung, K.; Pei, Y.; Leung, G. M.; Lam, T. T. Y.; Wu, J. T. title: Empirical transmission advantage of the D614G mutant strain of SARS-CoV-2 date: 2020-09-23 journal: nan DOI: 10.1101/2020.09.22.20199810 sha: 7adc3d35f0b2e4065931ca4f7b4422a1ad13bb37 doc_id: 834232 cord_uid: 3u0qrddf The SARS-CoV-2 lineage carrying the amino acid change D614G has become the dominant variant in the global COVID-19 pandemic. The rapid spread of the G614 mutant suggests that it may have a transmission advantage over the D614 wildtype. Using our previous epidemiological framework to analyze COVID-19 surveillance and sequence data, we estimated that the G614 mutant is 31% (28-34%) more transmissible than the D614 wildtype. As such, interventions that were previously effective in containing or mitigating the D614 wildtype (e.g. in China, Vietnam, Thailand, etc.) might be less effective against the G614 mutant. Our framework can be readily integrated into current COVID-19 surveillance to monitor the emergence and fitness of mutant strains, such that pandemic surveillance, disease control and development of treatment and vaccines can be adjusted dynamically. generations, assuming the mean generation time of 5-7 days). To minimize potential bias due to stochasticity in sampling, we only included countries with 100 or more sequences during the cocirculation period. Ten countries, namely Australia, Belgium, Denmark, Iceland, India, Netherlands, Spain, Portugal, the UK, and the US fulfilled these criteria and were included in our further analysis. In these ten countries, 515 D614 clusters and 1,420 G614 clusters among 10,915 sequences were identified, and the G614:D614 ratio increased over time and the G614 mutant rapidly became the dominant strain in these countries (Figure 2 ). Let ߪ be the ratio of the basic reproduction number of the G614 strain to that of the D614 strain, and ߬ be the ratio of the mean generation time of the G614 strain to that of the D614 strain. We assumed that the mean generation time of the D614 strain was 5.4 days 17 ߬ was 0.99 (0.96-1.00) across the ten countries. That is, the basic reproductive number of the G614 mutant was 31% (28-34%) higher than that of the D614 wildtype, and the mean generation time of the two strains were essentially the same. The fitted model was congruent with the observed proportions of G614 isolates over time in all ten countries ( Figure 3 ). If we used confirmed cases instead of confirmed deaths as the proxy for the COVID-19 epidemic curve ( Figure S2 and Figure S3 ), then ߪ was 1.23 (95% CrI 1.19-1.26) and ߬ was 0.96 (0.90-1.00). To assess potential geographical heterogeneity in the transmission advantage of the G614 mutant, we allowed ߪ to differ among the US, the UK and the remaining locations and reran the inference. The In the fitness estimation, by reconstructing co-circulating clusters of D614 and G614 using phylogenetic methods, we were able to exclude sequences from importations that generated no or limited secondary infections. However, the global phylogeny of SARS-CoV-2 suggested that most countries in Europe (such as UK 18 ) and the US received overwhelming importations of G614 since late February, possibly from countries with largely undetected outbreaks dominated by G614. To assess the effects of dominant introductions of G614, we incorporated G614 importation in the fitness estimation by specifically assuming the imported infections consisted of G614 only and the imported G614 force of infection was ߮ ீ times of the local COVID-19 incidence rate (see Methods). We performed a sensitivity analysis on sequences from the UK, which is among the countries with the largest number of SARS-CoV-2 genomes . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. suggesting that the dominant G614 importations was not driving the increase of G614 over time in UK ( Figure S4 ). Similarly, assuming ߮ ீ was the same in all the ten selected countries, the resulting ߮ ீ estimate was 0.0172 (0.0028-0.0271, Table S1 ). Although G614 introductions occurred later, more clusters with G614 were reconstructed in the ten selected countries and these clusters were larger on average. However, the size of clusters strongly depended on the sampling scheme and sequencing priority in each country. To assess the effects of sampling frequency in the G614 fitness estimation, we performed a sensitivity analysis on sequences from the UK. We included only clusters with at least 2, 3, 5, 10 or 20 different patient sequences in the fitness estimation ( Figure 4 ). We found that estimates of ߪ were not sensitive to the minimum cluster sizes up to 20 sequences. The estimations of ߪ were also not sensitive to the definitions of phylogenetic topology (i.e. "strict" and "relaxed" definitions; see Methods and Figure S1) used to identify the D614 and G614 local transmission clusters ( Figure 4 ). The inferred value of ߪ suggests that the herd immunity threshold for the G614 mutant is higher than that for the D614 wildtype. For example, if mixing is homogeneous, the excess is We estimated that IFRs were not statistically significant in locations where COVID-19 circulation was predominated by G614, though data were limited (Table S2 ). Although the virus with G614 seems to cause more mild and asymptomatic infections in Beijing's Xinfadi outbreak, intensive community testing was organized only in June (and thus more mild infections might have been identified) 21 ܴ . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.22.20199810 doi: medRxiv preprint were 3-4.5. By the same token, the critical vaccination coverage (which is equivalent to the herd immunity threshold) for G614 would be higher than that for D614. An alternative and less probable explanation for the faster doubling time of the G614 strain was that there was no change in R 0 but the mean generation time of the G614 mutant was around 20% shorter than that of the D614 wildtype. Using the first wave data of mainland Chinese city Guangzhou, we previously estimated that possibly 44% of all COVID-19 infection events were pre-symptomatic transmission and 95% of all transmission would have taken place by day 5 after symptom onset 28 . If the G614 virus were to spread faster but cause slightly milder illness, its current dominance would require more rapid response (20% faster) in contact tracing and testing to control any outbreak even at the very early stage. However, in this scenario, the critical vaccination coverage for the two strains would be the same because there is no difference in R 0 29 . Our study has several limitations. First, we only considered the D614G mutation and simply categorized the sequences on GISAID by aligning the spike protein region that contains the locus. We did not consider mutations in other loci that might provide necessary genetic background for D614G and act In conclusion, we have shown that the G614 mutation confers a transmission advantage over the wildtype D614. Monitoring the emergence of mutations and fitness of mutant strains are essential during the COVID-19 pandemic because the spread of mutants can attenuate the effectiveness of outbreak response . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.22.20199810 doi: medRxiv preprint and control interventions, such as development of therapy and vaccines. It is also important to acquire thorough understanding of viral phenotypes, clinical and epidemiological characteristics of emerging mutants like D614G of SARS-CoV-2, such that surveillance and disease control measures could be adjusted dynamically to counter the evolving risks posed by dominant mutant clades. Our method can be readily integrated into the analysis of phylogenetic data in the current COVID-19 surveillance system, to provide efficient epidemiological assessment of the transmission potential of emerging mutants for early alert. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.22.20199810 doi: medRxiv preprint For the convenience of mutation analysis, we first downloaded all the SARS-CoV-2 sequences submitted on or before 15 June 2020 from GISAID 2 . Multiple sequence alignment was constructed from the downloaded sequences. Then we labeled each sequence with either "D614" or "G614" based on the amino acid found at the 614th position in the translated amino acid sequences of the spike gene 4 . We excluded sequences with no explicit sample collection dates. In total, 35,377 sequences collected between 24 December 2019 and 8 June 2020 were used to construct the dataset. A phylogenetic tree was built from these global sequences with high sequencing coverages of the genomes, using maximum likelihood heuristic search and GTR+CAT nucleotide substitution model in FastTree v2.1.11 30 . We examined the global phylogeny to identify the different local transmission chains of D614 and G614 in each country, for the use in the fitness model described below. A strict monophyletic lineage of virus strains from the same country was defined as a local transmission cluster (hereinafter "strict" definition, Figure S1 ). A minimum of two sequences in such a cluster was considered as significant local transmission. We included countries with such clusters respectively of D614 and G614 that have cocirculated for a period at least two weeks (i.e. at least two disease generations, assuming the mean generation time of 5-7 days). To avoid potential bias due to stochasticity in sampling, we only included countries with 100 or more sequences during the co-circulation period. We identified 515 D614 clusters and 1,420 G614 clusters among 10,915 sequences in ten selected countries, namely Australia, Belgium, Denmark, Iceland, India, Netherlands, Spain, Portugal, the UK and the US. We also examined the effect of different cutoffs for minimum cluster size (2, 3, 5, 10 and 20) in our inference. Since the SARS-CoV-2 genomes evolved in a relatively slower rate and were intensively sampled, there were many unresolved polytomic nodes in the phylogeny and identical sequences from different countries 31 . This could potentially break a larger local transmission cluster into multiple smaller ones based on the above-mentioned "strict" definition. As such, we also considered a "relaxed" definition under which cluster and non-cluster sequences were grouped into an aggregated cluster if they shared the same parent nodes ( Figure S1 ). We evaluated the sensitivity of our fitness estimates to the "strict" and "relaxed" definitions. We also evaluated the sensitivity to the inclusion or exclusion of earliest sequence in each cluster which may represent the potential index case for the cluster and was less likely derived from the local sustained transmission chains. The model. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09. 22.20199810 doi: medRxiv preprint We assume that the mutation D614G is the only site of interest that results in potential difference in transmission advantage of SARS-CoV-2 throughout our analysis. We define the fitness of G614 as the ratio of the basic reproduction number of the strain with G614 to the strain with D614, i.e. We formulate the fitness inference framework under the following base case assumptions: (1) both D614 and G614 strains co-circulate locally during the period of fitness estimation; (2) non-pharmaceutical interventions (NPIs) have the same effect on the reproductive number of both strains; (3) the probability that an infected person is selected for viral sequencing is the same for both strains; (4) recovery from infection with either strain provides protection against reinfection of both strain during the period of estimation; and (5) was then estimated with other parameters in the inference with the likelihood specified below. Our method requires two streams of data. The first data stream is the incidence rate ݅ ሺ ‫ݐ‬ ሻ or its proxy, e.g. using the daily number of COVID-19 confirmed cases or deconvoluting the daily number of COVID-19 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We collated all data from publicly available data sources. All the information that we used is available in the main text or the supplementary materials. The authors declare no competing interests. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure S1 ). Each cluster stemmed from one or a small number of introductions and at least one transmission chain can be reconstructed from sequences within the same cluster. Only clusters sampled during the co-circulating period of D614 and G614 for at least two weeks in each country were included in the analysis. Only countries with more than 100 sequences were included in the analysis. The first/index case of each cluster was included in the analysis. The red lines indicated the date when major travel restriction from or to countries of European Union started. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.22.20199810 doi: medRxiv preprint The infection fatality risks in locations predominated by D614 or G614. To test the hypothesis that the G614 mutation might affect the clinical severity of SARS-CoV-2 infection, we estimated the infection fatality risks (IFRs) as the ratio of laboratory-confirmed deaths to the estimated number of infections in locations or settings with COVID-19 circulation predominated by D614 or G614. The daily number of confirmed deaths were obtained from the websites of local public health agencies. Table 2 ). The IFR estimates were lower but not significantly different among locations where COVID-19 circulation was dominated by G614, ranging from 0.43% (0.37-0.56) in Geneva, Switzerland to 0.83% (0.65-1.10) in New York City, US (Table S2) . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Iceland, India, Netherlands, Spain, Portugal, UK and US. Clusters with two or more sequences on GISAID were defined by phylogenetic methods with "strict" criteria. Each cluster stems from one or a small number of introductions and at least one transmission chain can be reconstructed from sequences within the same cluster. Only clusters sampled during the co-circulating period of D614 and G614 strains in each country were included in the analysis. Only countries with more than 100 sequences from at least 5 co-circulating clusters were included in the analysis. The red lines indicated the date when major travel restriction from or to countries of European Union started. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 1 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. * Assuming the number of reported local cases was close to the number of local infections because the ascertainment rates were ~100% in provinces outside Hubei given the intensive and proactive case finding § 7 days after the last week of the last estimate of seroprevalence, assuming it takes 21 days on average to develop consistently detectable antibodies after infection and the time between infection and deaths is 28 days is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.22.20199810 doi: medRxiv preprint (2020). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.22.20199810 doi: medRxiv preprint On the origin and continuing evolution of SARS-CoV-2 Global Initiative on Sharing All Influenza Data (GISAID) Viral and host factors related to the clinical outcome of COVID-19 Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide. bioRxiv Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America. medRxiv Updated analysis of SARS-CoV-2 spike protein variant D614G in the UK: evaluating evidence for effects on transmission How generation intervals shape the relationship between growth rates and reproductive numbers The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types. bioRxiv The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants A SARS-CoV-2 vaccine candidate would likely match all currently circulating strains Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity. medRxiv Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling study. The Lancet Infectious Diseases First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment COVID-19 Genomics UK (COG-UK) Consortium. SARS-CoV-2 genomic epidemiology in the UK A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2 Reemergent Cases of COVID-19-Xinfadi Wholesales Market Chinese Center for Disease Control and Prevention. Situation updates of Beijing's COVID-19 outbreask in Characteristics of COVID-19 infection in Beijing Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The Lancet Infectious Diseases Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China Temporal dynamics in viral shedding and transmissibility of COVID-19 Modeling infectious diseases in humans and animals FastTree 2-approximately maximum-likelihood trees for large alignments Tracking the genomic footprints of SARS-CoV-2 transmission Epidemiological characteristics of the first 53 laboratory-confirmed cases of COVID-19 epidemic in Hong Kong Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Chinese Center for Disease Control and Prevention. Dashboard of reported 2019-nCoV cases Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City. medRxiv